header logo image header logo text
Downloads Login
General Information
ZFIN ID: ZDB-EXP-100629-3
Experiment Conditions Description: chemical treatment: EC (non-specific serine/threonine protein kinase) inhibitor
chemical treatment: EC (non-specific serine/threonine protein kinase) inhibitor
Name: chemical treatment
Definition: Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000111]
Name: EC (non-specific serine/threonine protein kinase) inhibitor
Synonyms: A-kinase inhibitor, A-kinase inhibitors, AP50 kinase inhibitor, AP50 kinase inhibitors, ATP-protein transphosphorylase inhibitor, ATP-protein transphosphorylase inhibitors, ATP:protein phosphotransferase (non-specific) inhibitor, ATP:protein phosphotransferase (non-specific) inhibitors, betaIIPKC inhibitor, betaIIPKC inhibitors, BR serine/threonine-protein kinase 2 inhibitor, BR serine/threonine-protein kinase 2 inhibitors, calcium-dependent protein kinase C inhibitor, calcium-dependent protein kinase C inhibitors, calcium/phospholipid-dependent protein kinase inhibitor, calcium/phospholipid-dependent protein kinase inhibitors, cAMP-dependent protein kinase A inhibitor, cAMP-dependent protein kinase A inhibitors, cAMP-dependent protein kinase inhibitor, cAMP-dependent protein kinase inhibitors, casein kinase (phosphorylating) inhibitor, casein kinase (phosphorylating) inhibitors, casein kinase 2 inhibitor, casein kinase 2 inhibitors, casein kinase I inhibitor, casein kinase I inhibitors, casein kinase II inhibitor, casein kinase II inhibitors, casein kinase inhibitor, casein kinase inhibitors, cGMP-dependent protein kinase inhibitor, cGMP-dependent protein kinase inhibitors, CK-2 inhibitor, CK-2 inhibitors, CKI inhibitor, CKI inhibitors, CKII inhibitor, CKII inhibitors, cyclic AMP-dependent protein kinase A inhibitor, cyclic AMP-dependent protein kinase A inhibitors, cyclic AMP-dependent protein kinase inhibitor, cyclic AMP-dependent protein kinase inhibitors, cyclic monophosphate-dependent protein kinase inhibitor, cyclic monophosphate-dependent protein kinase inhibitors, cyclic nucleotide-dependent protein kinase inhibitor, cyclic nucleotide-dependent protein kinase inhibitors, cyclin-dependent kinase inhibitor, cyclin-dependent kinase inhibitors, dsk1 inhibitor, dsk1 inhibitors, EC (non-specific serine/threonine protein kinase) inhibitors, EC inhibitor, EC inhibitors, epsilon PKC inhibitor, epsilon PKC inhibitors, glycogen synthase a kinase inhibitor, glycogen synthase a kinase inhibitors, glycogen synthase kinase inhibitor, glycogen synthase kinase inhibitors, HIPK2 inhibitor, HIPK2 inhibitors, Hpr kinase inhibitor, Hpr kinase inhibitors, hydroxyalkyl-protein kinase inhibitor, hydroxyalkyl-protein kinase inhibitors, M phase-specific cdc2 kinase inhibitor, M phase-specific cdc2 kinase inhibitors, mitogen-activated S6 kinase inhibitor, mitogen-activated S6 kinase inhibitors, MKNK2 inhibitor, MKNK2 inhibitors, non-specific serine/threonine protein kinase (EC inhibitor, non-specific serine/threonine protein kinase (EC inhibitors, non-specific serine/threonine protein kinase inhibitor, non-specific serine/threonine protein kinase inhibitors, p21 activated kinase-1 inhibitor, p21 activated kinase-1 inhibitors, p82 kinase inhibitor, p82 kinase inhibitors, PAK-1 inhibitor, PAK-1 inhibitors, PAK1 inhibitor, PAK1 inhibitors, phosphorylase b kinase kinase inhibitor, phosphorylase b kinase kinase inhibitors, PKA inhibitor, PKA inhibitors, protein glutamyl kinase inhibitor, protein glutamyl kinase inhibitors, protein kinase (phosphorylating) inhibitor, protein kinase (phosphorylating) inhibitors, protein kinase A inhibitor, protein kinase A inhibitors, protein kinase CK2 inhibitor, protein kinase CK2 inhibitors, protein kinase p58 inhibitor, protein kinase p58 inhibitors, protein phosphokinase inhibitor, protein phosphokinase inhibitors, protein serine kinase inhibitor, protein serine kinase inhibitors, protein serine-threonine kinase inhibitor, protein serine-threonine kinase inhibitors, protein-aspartyl kinase inhibitor, protein-aspartyl kinase inhibitors, protein-cysteine kinase inhibitor, protein-cysteine kinase inhibitors, protein-serine kinase inhibitor, protein-serine kinase inhibitors, protein-serine/threonine kinase inhibitors, Prp4 protein kinase inhibitor, Prp4 protein kinase inhibitors, Raf kinase inhibitor, Raf kinase inhibitors, Raf-1 inhibitor, Raf-1 inhibitors, ribosomal protein S6 kinase II inhibitor, ribosomal protein S6 kinase II inhibitors, ribosomal S6 protein kinase inhibitor, ribosomal S6 protein kinase inhibitors, serine kinase inhibitor, serine kinase inhibitors, serine protein kinase inhibitor, serine protein kinase inhibitors, serine(threonine) protein kinase inhibitor, serine(threonine) protein kinase inhibitors, serine-specific protein kinase inhibitor, serine-specific protein kinase inhibitors, serine/threonine protein kinase inhibitor, serine/threonine protein kinase inhibitors, STK32 inhibitor, STK32 inhibitors, T-antigen kinase inhibitor, T-antigen kinase inhibitors, threonine-specific protein kinase inhibitor, threonine-specific protein kinase inhibitors, twitchin kinase inhibitor, twitchin kinase inhibitors, type-2 casein kinase inhibitor, type-2 casein kinase inhibitors, Wee 1-like kinase inhibitor, Wee 1-like kinase inhibitors, Wee-kinase inhibitor, Wee-kinase inhibitors, WEE1Hu inhibitor, WEE1Hu inhibitors
Definition: An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC, a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine.
Ontology: Chebi [CHEBI:50925]
Publication: Alvarez et al., 2009